Contract 75F40122C00196
The Critical Path Institute · Department Of Health And Human Services · September 26, 2022
The Critical Path Institute was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 26, 2022 for $225,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on February 19, 2026. If all options are exercised, the contract could reach $3.71 million.
Contract details
- PIID
- 75F40122C00196
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Silver Spring, MD
- First action
- September 26, 2022
- Latest action
- February 19, 2026
Description
TERMINATION SETTLEMENT MODIFICATION
Modification timeline
-
February 19, 2026Mod P00007 · Supplemental Agreement For Work Within Scope$1.67M
-
September 26, 2022Base awardBAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.$2.38M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00196?
Contract 75F40122C00196 is a federal contract awarded to The Critical Path Institute by Department Of Health And Human Services on September 26, 2022 for $225,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40122C00196?
The Critical Path Institute won contract 75F40122C00196 from Department Of Health And Human Services.
How much is contract 75F40122C00196 worth?
Contract 75F40122C00196 has obligated $225,000 to date, with a total potential value of $3.71 million if all options are exercised.